About
Allecra Therapeutics develops innovative peptide-based therapeutics for the treatment of autoimmune diseases and cancer by creating immune modulators that selectively target intracellular pathways.
Explore Allecra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.